Journal
ANTI-CANCER DRUGS
Volume 21, Issue 2, Pages 140-150Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CAD.0b013e32833498f1
Keywords
glioma; oxidative stress; resveratrol; tumour progression
Categories
Funding
- FIRST 2008 (Fondo Interno Ricerca Scientifica a Tecnologica), University of Milan
- Fondazione Ariel, Centro per le Disabilita Neuromotorie Infantili, Milan, Italy
- Fondazione Monte dei Paschi di Siena, Siena, Italy
Ask authors/readers for more resources
There is growing interest in dietary phytochemicals as potential cancer chemopreventive agents. Resveratrol (3,4',5-trihydroxy-trans-stilbene), a naturally occurring phytoalexin that is present in grapes, red wine, berries and peanuts, has been studied extensively for its ability to interfere with multistage carcinogenesis. Resveratrol is known to have antioxidant, anti-inflammatory and anti proliferative effects on a variety of cancer cells in vitro and in various animal models. However, the effect(s) of resveratrol in vivo on humans are still controversial. This study discusses current knowledge with regard to the effects of resveratrol in relation to its potential as a chemopreventive and/or chemotherapeutic molecule against human gliomas. Anti-Cancer Drugs 21:140-150 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available